Compare Nuwellis Inc (NUWE) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Rocket Lab USA Inc — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Rocket Lab USA Inc trades at $63.43 (market cap $42.12B). The key difference: Rocket Lab USA Inc is far larger — about 16848× Nuwellis Inc's market cap, and Rocket Lab USA Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | RKLB | |
|---|---|---|
Market Cap | $2.50M | $42.12B |
Sector | Technology | Technology |
52-Week High | $164.50 | $150.23 |
52-Week Low | $0.73 | $39.48 |
Enterprise Value | -$1.21M | $39.95B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Rocket Lab (RKLB) trades at $65.87, up 2.51% on the day, but remains in a bearish technical trend below key resistance levels. The company reported record Q2 2026 revenue of $234 million, up 62% year-over-year, yet continues to post significant net losses. Recent news highlights progress on the Neutron rocket and the pending Iridium Communications acquisition, but investor sentiment is mixed due to execution risks and delays.
The outlook hinges on successful Neutron deployment and path to profitability. Analysts see substantial upside with a $117.44 consensus target, but risks include cash burn, competitive pressure, and potential further launch delays. The stock offers high-growth potential for risk-tolerant investors betting on the space economy's expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
